Chargement en cours...
Recent Advances in the Cellular and Molecular Understanding of Myelodysplastic Syndromes: Implications for New Therapeutic Approaches
It has been more than 10 years since any new disease-modifying therapies have received regulatory approval for indications related to myelodysplastic syndromes (MDS). Advances in our collective biological understanding of MDS in the last decade, however, have made it possible to hope that effective...
Enregistré dans:
| Publié dans: | Clin Adv Hematol Oncol |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6629038/ https://ncbi.nlm.nih.gov/pubmed/29741506 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|